Generali Investments Towarzystwo Funduszy Inwestycyjnych Jazz Pharmaceuticals PLC Transaction History
Generali Investments Towarzystwo Funduszy Inwestycyjnych
- $189 Billion
- Q3 2025
A detailed history of Generali Investments Towarzystwo Funduszy Inwestycyjnych transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Generali Investments Towarzystwo Funduszy Inwestycyjnych holds 1,250 shares of JAZZ stock, worth $176,337. This represents 0.09% of its overall portfolio holdings.
Number of Shares
1,250
Previous 1,250
-0.0%
Holding current value
$176,337
Previous $133 Million
24.2%
% of portfolio
0.09%
Previous 0.07%
Shares
7 transactions
Others Institutions Holding JAZZ
# of Institutions
573Shares Held
61.9MCall Options Held
856KPut Options Held
178K-
Black Rock Inc. New York, NY6.15MShares$867 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.91MShares$833 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.84MShares$400 Million0.08% of portfolio
-
Capital World Investors Los Angeles, CA2.55MShares$360 Million0.05% of portfolio
-
Lsv Asset Management Chicago, IL2.51MShares$354 Million0.73% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.84B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...